NIH Partnership To Pick COVID-19 Therapeutics For Clinical Trials; Results Anticipated By Summer

 
• By Brenda Sandburg

NIH public-private partnership with FDA, CDC, BARDA and 16 biopharma companies to rank most promising therapeutics and vaccines to advance into clinical trials; candidates expected to be tested simultaneously under master protocol.

word speech bubble illustration of business acronym term Public-private partnership
NIH public private partnership aims to speed COVID-19 therapeutic candidates into clinical trials

More from Clinical Trials

More from R&D